April 12, 2012Journal of Hypertension
Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies
Population
30,424 patients with vascular disease or complicated diabetes who were in sinus rhythm at entry, mean age…
Design
Cohort
Follow-up
median 4.7 years
Authors
Discussion
Loading...
Member takes
Implication
New AF signals elevated HF and CV death risk in vascular patients; extends prior associations but leaves causal inference and intervention targets open.
Structured PICO
P
Population
30,424 patients with vascular disease or complicated diabetes who were in sinus rhythm at entry, mean age 66.4 ± 7.0 years.
O
Outcome
New-onset atrial fibrillationhard clinical
In high-risk vascular patients, new-onset atrial fibrillation is common and significantly increases the risk of subsequent congestive heart failure and cardiovascular death.
Cite This Study
Verdecchia et al. (2012) studied this question.